MYC-bound enhancer RNAs in cis regulate gene transcription and tumorigenesis
Science Advances · 24.04.2026 · 12 (17)
DOI: 10.1126/sciadv.aeb5147 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 24.04.2026. Verfasst von Sihan Li und 15 weiteren Autor:innen. Beteiligte Einrichtung: Center for Pharmacogenetics, Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, PA, USA. Hauptthemen laut MEDLINE: Enhancer RNAs, Gene Expression Regulation, Neoplastic, Proto-Oncogene Proteins c-myc, Carcinogenesis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIBIB NIH HHS, NIMH NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Emerging evidence suggests that MYC binds RNAs, but its functional consequences remain unclear. Here, we integrate multiomics data and reveal that MYC broadly binds enhancer RNAs (eRNAs), which exhibit high cancer- and tissue-specific expression in cancer cell lines and patient tumors. Moreover, we developed a computational pipeline to identify potential cis-regulatory MYC-eRNA target genes, with most predicted eRNA-target pairs supported by RNA polymerase II–mediated chromatin interaction data. Among these, we functionally characterized MERG1 as an oncogenic eRNA that promotes breast cancer tumorigenesis. Mechanistically, MERG1 interacts with MYC to enhance its occupancy at the GREB1 promoter, driving chromatin remodeling and epigenetic activation. This process specifically amplifies GREB1 expression and promotes tumor progression. Last, nanoparticle-mediated delivery of antisense oligonucleotides targeting MERG1 suppresses MYC-mediated breast cancer growth. These results advance our understanding of the enhancer-driven regulation of gene expression and tumorigenesis and provide insights into the regulatory landscape of MYC in cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Pharmacogenetics, Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, PA, USA.
- Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
- UPMC Hillman Cancer Institute, University of Pittsburgh, Pittsburgh, PA, USA.
- Department of Bioengineering, Department of Electrical and Computer Engineering, Cancer Center at Illinois, Beckman Institute for Advanced Science and Technology, University of Illinois Urbana-Champaign, Urbana, IL, USA.
ORCID-Profile: Sihan Li, Zehua Wang, Phuong Nguyen, Yue Wang, Yueshan Zhao, Yifei Wang, Yuang Chen, Xiaofei Wang, Dhamotharan Pattarayan, Min Zhang, Yang Liu, Song Li, Da Yang
Förderung
- NIBIB NIH HHS
- NIMH NIH HHS
- NCI NIH HHS
- National Institutes of Health
- National Cancer Institute
- National Institute of Biomedical Imaging and Bioengineering
- University of Pittsburgh Center for Research Computing
Zitieren
APA
Li, S., Wang, Z., Nguyen, P., Wang, Y., Zhao, Y., Wang, Y., Chen, Y., Huang, H., Wang, X., Zhang, Y., Huang, Y., Pattarayan, D., Zhang, M., Liu, Y., Li, S., & Yang, D. (2026). MYC-bound enhancer RNAs in cis regulate gene transcription and tumorigenesis. Science Advances, 12(17). https://doi.org/10.1126/sciadv.aeb5147
Vancouver
Li S, Wang Z, Nguyen P, Wang Y, Zhao Y, Wang Y, et al. MYC-bound enhancer RNAs in cis regulate gene transcription and tumorigenesis. Science Advances. 2026;12(17). doi:10.1126/sciadv.aeb5147
BibTeX
@article{Li2026,
author = {Li, Sihan and Wang, Zehua and Nguyen, Phuong and Wang, Yue and Zhao, Yueshan and Wang, Yifei and Chen, Yuang and Huang, Haozhe and Wang, Xiaofei and Zhang, Yu and Huang, Yixian and Pattarayan, Dhamotharan and Zhang, Min and Liu, Yang and Li, Song and Yang, Da},
title = {MYC-bound enhancer RNAs in cis regulate gene transcription and tumorigenesis},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {17},
doi = {10.1126/sciadv.aeb5147}
}
EUVIMED